Clinical and angiographic results after implantation of a passive-coated coronary stent in patients with acute myocardial infarction

Journal of Invasive Cardiology

Volumn 20, Issue 1, 2008, Pages 9-13

  Özbek, Cem ^a,d   Bay, Wolfgang ^a   Jochum, Lorenz ^a   Jung, Friedrich ^b   Bach, Roland ^c  

^a Volklingen Heart Centre   (Germany)

^b Berlin Brandenburg Center for Regenerative Therapies   (Germany)

^c Institut for Heart and Circulation Research

^d Internal Medicine Clinic I   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOGENIC SHOCK; CHOLESTEROL BLOOD LEVEL; CLINICAL STUDY; CORONARY STENT; DIABETES MELLITUS; EXERCISE TEST; FEMALE; FOLLOW UP; HEART REINFARCTION; HEART STRESS; HUMAN; HYPERTENSION; HYPOTHESIS; IMPLANTATION; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; REGISTER; REVASCULARIZATION; SUDDEN DEATH;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMERS; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STENTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 37849032358     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Mudra H, Levenson B, Bode C, et ak. Positionspapier zum Einsatz von medikamente freisetzenden stents bei patienten mit koronarer herzerkrankung. Z Kardiol 2004;93;416-422.
2. Gruberg L, Suleiman M, Kapeliovich M, et al. Glycoprotein IIb/IIIa inhibitors during rescue pefcutaneous coronary intervention in acute myocardial infarction. J Invasive Cardiol 2006;18:63-64.
3. Lavi S, Gruberg L, Kapeliovich M, et al. The impact of GP IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction patients. J Invasive Cardiol 2005;17:300-301.
4. Lee CH, van Domburg RT, Hoye A, et al. Predictors of survival after revascularization for acute myocardial infarction in the real world. J Invasive Cardiol 2004;16:627-631.
5. Myocardial infarction redefined - A consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:956-969.
6. Hoffmann M, Horres R, Keller R, Baumann H. Isolation and characterisation of endothelial cell surface heparan sulphate from whole bovine lung for coating of biomaterials to improve haemocompatibility. In: Biomedical Polymers and Polymer Therapeutics. (Chiellini E, Sunamoto J, Migliaresi C, et al). New York: Kluwer Academic. 2001, pp. 213-226.
7. Hoffmann M, Huppertz B, Horres R, et al. Endothelial cell surface heparan sulphate and synthetic heparin derivatives as hemocompatible coating for biomaterials. Mat-wiss. u. Werkstofftechn. 2001;32:110-115.
8. Taylor A. Metals. In: Endoluminal Stenting. U. Sigwart (ed.). London: W.B. Saunders Company. 1996, pp. 28-33.
9. Jung F, Mrowietz C, Seyfert UT, et al. Influence of the direkt NO-donor SIN-1 on the interaction between platelets and stainless steel stents under dynamic conditions. Clin Hemorheol Microcirc 2003;28:189-199.
10. Seyfert UT, Mörsdorf S, Riggert J, Jung F. Biochemische Analytik der Hämokompatibilität. Clin Lab 1997;43:571-582.
11. Mrowietz C, Franke RP, Seyfert UT, et al. Haemo-compatibility of polymer-coated stainless steel stents as compared to uncoated stents. Clin Hemorheol Microcirc 2005;32:89-103.
12. Harrop J, Donnelly R, Rowbottom A, et al. Improvements in total mortality and lipid levels after acute myocardial infarction in an English health district (1995-1999). Heart 2002;87:428-431.
13. Beohar N, Davidson CJ, Weigold G, et al. Predictors of long-term outcomes following direct percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 2001;88:1103-1107.
14. Heggunje PS, Harjai KJ, Stone GW, et al. Procedural success versus clinical risk status in determining discharge of patients after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004;44:1400-1407.
15. Lemos PA, Saia F, Hofma SH, et al. Short and long-term clinical benefit of Sirolimus-eluting stents compared to conventional bare metal stents for patients with acute myocardial infarction. J Am Coll Cardiol 2004;43:704-708.
16. Grines C, Patel A, Zijlstra F, Weaver WD, Granger C, Simes RJ, PCAT Collaboraters. Percutaneous transluminal coronary angioplasty. Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: Six-month follow up and analysis of individual patient data from randomized trials. Am Heart J 2003;145:47-57.
17. Le May MR, et al. Stenting versus thrombolysis in acute myocardial infarction. J Am Coll Cardiol 2001;37:985-991.
18. Weber F, Schneider H, Schwarz C, et al. Sirolimus-eluting stents for percutaneous coronary intervention in acute myocardial infarction of bare-metal versus drug-eluting stents in thrombus-laden lesions. Lesson from a case-controlled comparison. Z Kardiol 2004;93:938-943.
19. Spaulding C, Henry P, Teiger E, et al, for the TYPHOON Investigators. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006;355:1093-1104.
20. Dudek D, Mielecki W, Wizimirski M, et al. Primary coronary angioplasty in patients with ST segment elevation acute myocardial infarction and diabetes. Kardiol Pol 2004;61:232-241.
21. Yip HK, Hang CL, Fang CY, et al. Level of high-sensitivity C-reactive protein is predictive of 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention. Chest 2005;127:803-808.
22. Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: Results from the PREMIER registry. Circulation 2006;113:2803-2809.